West-Ward Columbus Inc. FDA Inspection Record

FEI 1510690 · Inspections, Form 483s, warning letters and import refusals

West-Ward Columbus Inc. is an FDA-registered facility (FEI 1510690) located in Columbus, OH, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION. RegDataLab tracks 28 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
Sep 18, 2026: No Action Indicated (NAI)
Inspections on record
28 (4 VAI, 24 NAI)
Last OAI inspection
None on record
Warning letters
2 listed by FDA for this FEI, latest Mar 30, 2009
Recalls as the recalling firm
41, latest Oct 20, 2026
Import refusals
9

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 28 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 18, 2026No Action Indicated (NAI)No citations listed
Apr 30, 2026No Action Indicated (NAI)No citations listed
Jan 17, 2025No Action Indicated (NAI)No citations listed
Jul 23, 2024No Action Indicated (NAI)No citations listed
Sep 15, 2022No Action Indicated (NAI)No citations listed
Nov 22, 2019No Action Indicated (NAI)No citations listed
Apr 16, 2019No Action Indicated (NAI)No citations listed
Apr 18, 2018Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Label storage access limited to authorized personnel (21 CFR 211.122(d))
Sep 19, 2017No Action Indicated (NAI)No citations listed
Aug 29, 2017No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 41 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 20, 2026Class IID-0165-2027Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma… and 1 more product
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Oct 6, 2026Class IID-0076-2027Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for…
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Aug 24, 2026Class IID-0831-2026Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500…
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Apr 7, 2026Class IID-0526-2026Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose…
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Dec 19, 2024Class IIID-0183-2025Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed…
Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
Sep 22, 2023Class IIID-0066-2024Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only…
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet…
Jul 22, 2020Class IIID-1490-2020Leucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by…
Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.
May 13, 2020Class IID-1274-2020Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC…
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification…
May 13, 2020Class IIID-1282-2020Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward…
Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.
Sep 9, 2019Class IID-1863-2019Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by…
Failed Impurities/Degradation Specificattion

FDA record score

22 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

30 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-0165-2027, this FEI as the recalling firmOct 20, 20264 x 14
Class II recall D-0076-2027, this FEI as the recalling firmOct 6, 20264 x 14
Class II recall D-0831-2026, this FEI as the recalling firmAug 24, 20264 x 14
Class II recall D-0526-2026, this FEI as the recalling firmApr 7, 20264 x 14
Inspection classified VAIApr 18, 20186 x 0.251.5
Class II recall D-1274-2020, this FEI as the recalling firmMay 13, 20204 x 0.251
Class II recall D-1863-2019, this FEI as the recalling firmSep 9, 20194 x 0.251
Class II recall D-1024-2018, this FEI as the recalling firmJul 24, 20184 x 0.251
Class II recall D-0437-2017, this FEI as the recalling firmDec 22, 20164 x 0.251
Inspection classified VAIOct 21, 201610 years or older, so it adds no points0
Class II recall D-0008-2017, this FEI as the recalling firmOct 3, 201610 years or older, so it adds no points0
Class II recall D-1279-2015, this FEI as the recalling firmJul 24, 201510 years or older, so it adds no points0
Class II recall D-1085-2015, this FEI as the recalling firmApr 2, 201510 years or older, so it adds no points0
Inspection classified VAIJun 26, 201410 years or older, so it adds no points0
Class II recall D-1427-2014, this FEI as the recalling firmMay 1, 201410 years or older, so it adds no points0
Class II recall D-002-2014, this FEI as the recalling firmApr 3, 201310 years or older, so it adds no points0
Class II recall D-067-2013, this FEI as the recalling firmNov 5, 201210 years or older, so it adds no points0
Inspection classified VAIJan 20, 201110 years or older, so it adds no points0
Class II recall D-829-2011, this FEI as the recalling firmNov 30, 201010 years or older, so it adds no points0
Class II recall D-164-2011, this FEI as the recalling firmOct 28, 201010 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMar 30, 200910 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMar 30, 200910 years or older, so it adds no points0
Class I recall D-196-2009, this FEI as the recalling firmJul 10, 200810 years or older, so it adds no points0
Class II recall D-196-2008, this FEI as the recalling firmMar 3, 200810 years or older, so it adds no points0
Class II recall D-840-2007, this FEI as the recalling firmMay 14, 200710 years or older, so it adds no points0
Class II recall D-335-6, this FEI as the recalling firmJul 31, 200610 years or older, so it adds no points0
Class I recall D-337-6, this FEI as the recalling firmJul 10, 200610 years or older, so it adds no points0
Class II recall D-266-6, this FEI as the recalling firmMay 24, 200610 years or older, so it adds no points0
Class II recall D-468-5, this FEI as the recalling firmJul 26, 200510 years or older, so it adds no points0
Class II recall D-150-5, this FEI as the recalling firmJan 17, 200510 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing West-Ward Columbus Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check West-Ward Columbus Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Hikma Pharmaceuticals USA INC.
Location
Columbus, OH (US)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.